What is a Schedule 8 medication?

A controlled substance in Australia subject to strict prescribing and dispensing regulations due to potential for abuse and dependence.

Published: 3 April 2026 | Updated: 3 April 2026

Definition and Classification

Schedule 8 medications are a category of controlled substances under Australian medicines law. They are drugs with high potential for abuse and dependence, requiring strict regulatory controls over prescribing, dispensing, storage, and record-keeping. Schedule 8 medications are the most tightly regulated prescription medications in Australia.

The Australian Therapeutic Goods Administration (TGA) classifies medications into schedules based on the level of control needed. Schedule 8 represents the highest level of control for prescription medicines (Schedule 9 covers prohibited substances).

Common Schedule 8 Medications

Schedule 8 medications include:

Opioids

Strong pain relievers, including morphine, oxycodone, fentanyl, hydromorphone, and others. These are the most commonly prescribed Schedule 8 medications in insurance claims, used for moderate to severe pain management. Opioids carry high potential for dependence and abuse.

Benzodiazepines

Sedatives and anxiety treatments, including diazepam, alprazolam, and others. These are frequently prescribed for anxiety or insomnia but carry significant dependence risks with long-term use.

Stimulants

Medications such as methylphenidate and dexamphetamine, used primarily for attention deficit disorders. These carry dependence potential, though in therapeutic use for appropriate indications, the risk is generally low.

Anabolic Steroids

Medications with legitimate medical uses but high abuse potential. In insurance claims, these are rarely prescribed but may appear in some rehabilitation contexts.

Other Controlled Substances

Including some anticonvulsants, barbiturates, and other substances with specific abuse or dependence potential.

Prescribing Requirements for Schedule 8 Medications

In Australia, Schedule 8 medications require compliance with specific prescribing rules:

Prescriber Qualifications

Only authorised prescribers can prescribe Schedule 8 medications. These are typically doctors, dentists, veterinarians, and some other qualified practitioners. Prescribers must be registered and in good standing with their professional body.

Prescription Requirements

Schedule 8 prescriptions have specific format requirements, including:

• Handwritten prescriptions (in most states)
• Patient name and address
• Drug name and strength
• Quantity in words and numbers
• Dosage and directions
• Prescriber signature and details
• Date of prescription

Dispensing Requirements

Pharmacies must:

• Verify the prescription is authentic and properly completed
• Check that the dose and quantity are appropriate
• Maintain records of all Schedule 8 dispensing
• Provide the medication in specific packaging with appropriate labelling
• Counsel the patient on appropriate use and risks

Schedule 8 Regulations in Different States

While the Therapeutic Goods Administration sets national standards, state and territory governments also regulate Schedule 8 medications. There are minor variations between states, particularly regarding prescribing formats and record-keeping requirements. If your claimant is in multiple jurisdictions or moving between states, ensure the medication management complies with local requirements.

Why Schedule 8 Status Matters in Insurance Claims

Schedule 8 medications are particularly important in insurance claims for several reasons:

Dependence Risk

Schedule 8 medications carry genuine dependence risk. Long-term use of opioids or benzodiazepines can lead to physical dependence, making withdrawal difficult. Your claims management needs to address this risk through regular review and planned deprescribing.

Abuse and Diversion Risk

These medications have street value and abuse potential. You need to be alert to signs that a claimant may be misusing prescribed Schedule 8 medications or that medications may be being diverted. Red flags include requests for early refills, reports of lost prescriptions, or acquiring Schedule 8 medications from multiple prescribers.

Regulatory Compliance

Ensuring Schedule 8 medications are prescribed and dispensed in compliance with regulations is important. Non-compliance creates legal liability.

Opioid-Related Harm

Opioids particularly carry significant risks of overdose, respiratory depression, and other serious adverse effects. The opioid dependency crisis has highlighted the importance of careful opioid prescribing and monitoring.

Red Flags for Problematic Schedule 8 Use

Be alert to these warning signs:

• Requests for early refills or higher doses
• Reports of lost or stolen medications
• Obtaining Schedule 8 medications from multiple prescribers without coordination
• Signs of medication misuse, such as slurred speech or impaired cognition
• Escalating doses without clear clinical reason
• Reluctance to discuss medication use or try deprescribing
• History of substance abuse or addiction
• Claimant appearing intoxicated or sedated when on prescribed opioids

Opioid Management in Insurance Claims

Opioids are the most frequently prescribed Schedule 8 medication in insurance claims. If your claimant is on opioids, ensure:

• Clear indication: There is a documented, ongoing reason for opioid therapy
• Regular review: Opioid therapy is reviewed regularly (at least annually) to ensure it remains appropriate
• Monitoring: The claimant is monitored for signs of dependence, misuse, or adverse effects
• Non-opioid alternatives: Non-medication approaches and non-opioid medications have been tried or considered
• Deprescribing planning: There is a plan for eventual deprescribing when pain management goals change
• Multiple prescriber awareness: All prescribers are aware of opioid therapy to prevent duplication

Benzodiazepine Considerations

Benzodiazepines, while Schedule 8, are frequently problematic in insurance claims because they are often continued long-term when guidelines recommend short-term use. If your claimant is on long-term benzodiazepines:

• Understand why long-term use is necessary (guidelines recommend short-term use only)
• Assess dependence risk and whether deprescribing should be planned
• Monitor for adverse effects such as falls, confusion, or cognitive decline
• Ensure alternatives have been tried or considered
• Plan for eventual deprescribing, with medical support

Your Role in Schedule 8 Medication Management

As an insurer, you can support appropriate Schedule 8 use by:

• Flagging Schedule 8 medications for pharmacist review
• Requesting evidence that there is clear, ongoing indication for the medication
• Monitoring for red flags indicating misuse or dependence
• Supporting deprescribing when appropriate
• Ensuring compliance with prescribing and dispensing regulations
• Coordinating with multiple prescribers if the claimant is on Schedule 8 from several sources